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however the mechanisms by which Hh signals are interpreted by placodal cells are unknown. Here we show
distinct temporal requirements for Hh signaling in endocrine cell differentiation and describe a dynamic Gli
transcriptional response code that interprets these Hh signals within the developing adenohypophysis. Gli1
is required for the differentiation of selected endocrine cell types and acts as the major activator of Hh-
mediated pituitary induction, while Gli2a and Gli2b contribute more minor activator functions. Intriguingly,
this Gli response code changes as development proceeds. Gli1 continues to be required for the activation of
the Hh response anteriorly in the pars distalis. In contrast, Gli2b is required to repress Hh target gene
expression posteriorly in the pars intermedia. Consistent with these changing roles, gli1, gli2a, and gli2b, but
not gli3, are expressed in pituitary precursor cells at the anterior neural ridge. Later in development, gli1
expression is maintained throughout the adenohypophysis while gli2a and gli2b expression are restricted to
the pars intermedia. Given the link between Hh signaling and pituitary adenomas in humans, our data
suggest misregulation of Gli function may contribute to these common pituitary tumors.
© 2008 Elsevier Inc. All rights reserved.Introduction
The vertebrate pituitary gland is comprised of a neurally derived
lobe, the neurohypophysis, and an epidermally derived lobe, the
adenohypophysis. The structure of the adenohypophysis is highly
conserved across vertebrates, with the lobe being divided into two
subdomains along the anterior/posterior (A/P) axis (Liem et al., 2001;
Wilson and Wyatt, 1986). The anterior region, or pars distalis (PD),
contains lactotropes, corticotropes, thyrotropes, and gonadotropes,
while the posterior region, the pars intermedia (PI), contains some
thyrotropes and all melanotropes (Guner et al., 2008; Herzog et al.,
2003; Sbrogna et al., 2003; Wilson and Wyatt, 1986).
The adenohypophysis forms early in embryonic development as a
midline cranial placode through a thickening and/or invagination of
epithelial cells (Schlosser, 2006). In mammals, oral ectoderm
invaginates to form Rathke's pouch, which thickens to form the
adenohypophysis. Fate mapping studies in mammals indicate that
Rathke's pouch is derived from cells at the anterior neural ridge (ANR)
of the neural plate stage embryo (Kouki et al., 2001). Similarly,strom).
t.
l rights reserved.zebraﬁsh fate mapping studies show that the adenohypophysis is
derived from cells at the ANR that comprise an equivalence domain
that can form pituitary or lens (Dutta et al., 2005). The early
developmental program for adenohypophysis formation appears to
be largely conserved across vertebrate species, with a number of
signaling molecules (e.g. sonic hedgehog, (Shh), ﬁbroblast growth
factor (Fgf), and bonemorphogenetic protein (Bmp)) and transcription
factors (e.g. Pitx3, Lim3) contributing to both the initial induction of
the placode and the differentiation of speciﬁc endocrine cell types
(reviewed in Pogoda and Hammerschmidt, 2007).
The secreted protein Sonic hedgehog is necessary for pituitary
formation across vertebrate species (Dutta et al., 2005; Herzog et al.,
2003; Sbrogna et al., 2003; Treier et al., 2001). Human (Roessler et al.,
2003), mouse (Treier et al., 2001) and zebraﬁsh Hedgehog (Hh)
pathway mutants lack a pituitary, with more severe loss of Hh
signaling in zebraﬁsh leading to the formation of an ectopic lens in
place of the adenohypophysis (Karlstrom et al., 1999; Kondoh et al.,
2000; Varga et al., 2001). This requirement for Hh signaling in the
developing pituitary placode appears to be direct based on the
expression of Hh responsive genes in the adenohypophysis (Guner et
al., 2008; Sbrogna et al., 2003) and on data showing that targeted
disruption of Hh signaling in oral ectoderm causes pituitary
hypoplasia and the loss of ventral cell types (Treier et al., 2001). We
previously showed that Hh signals from the central nervous system
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lim3 (lhx3) in pre-placodal cells at the ANR at around 15 h post
fertilization (hpf) in zebraﬁsh (Sbrogna et al., 2003). Further, graded
Hh and Fgf (likely Fgf3, Herzog et al., 2004) signals from the CNS play a
role in functional patterning of the placode along the A/P axis and
establishing the PD and PI regions early in placode development
(Guner et al., 2008). These studies indicate that Hh is one of the ﬁrst
inductive signals for pituitary cell fates, and that Hh continues to play
a role in endocrine cell differentiation as the placode is patterned.
The Hh signaling pathway is highly conserved from insects to
mammals, with Hh signals being mediated in responding cells by the
Gli family of zinc ﬁnger transcription factors. Hh/Gli signaling can
induce a variety of cellular responses depending on the context of
signaling (Ruiz i Altaba et al., 2007). These responses include cell
differentiation through the activation and repression of homeobox
transcription factors, as well as regulation of cell proliferation and cell
survival (Cayuso et al., 2006). In Drosophila, the cellular response to
Hh is regulated by activator and repressor activities of a single
bifunctional gli homologue, Cubitus interruptus (Ci). In the absence of
Hh signals, Ci cleavage results in a truncated transcription factor that
represses expression of Hh target genes. Signaling by Hh results in the
formation of a full length protein that activates expression of Hh target
genes (Aza-Blanc et al., 1997; Methot and Basler, 2001). In vertebrates,
these activator and repressor functions are distributed among at least
three Gli proteins, with a complex code of activator and repressor Gli
function determining the cellular response to different levels of Hh
signals. In the mouse neural tube, Gli2 is a major activator of Hh-
mediated dorsoventral patterning events, while Gli1 appears to play a
minor activator role, and both Gli2 and Gli3 have activator and
repressor roles (Ruiz i Altaba, 1999). In zebraﬁsh, most aspects of Gli
functionality are conserved, however Gli1 rather than Gli2 appears to
be the major activator of the early Hh response in the CNS (Karlstrom
et al., 2003; Tyurina et al., 2005; Vanderlaan et al., 2005). Two gli2
genes (gli2a and gli2b) have been identiﬁed in zebraﬁsh that are likely
to have arisen as the result of a partial genome duplication in the
teleost lineage (Ke et al., 2005). While both Gli2 proteins appear to
have similar Hh-dependent activator roles in the nervous system, the
identiﬁcation of an additional role for Gli2b in the regulation of cell
proliferation suggests that there has been some divergence in the
function of gli2a and gli2b over evolutionary time (Ke et al., 2008).
Despite a well-established role for the Gli transcription factors in
neural patterning, little is known about how the different gli genes
function in endocrine tissues. A role for Gli-mediated Hh signaling in
pituitary development has been demonstrated genetically, as zebra-
ﬁsh mutations in Gli1 lead to defects in pituitary patterning and cell
speciﬁcation (Karlstrom et al., 2003; Sbrogna et al., 2003). These
defects are less severe than those seen in mutations affecting Shh or
Smoothened, the major transmembrane mediator of Hh signaling,
suggesting multiple Gli genes may help mediate Hh signaling in the
adenohypophysis. Here we show that Gli-mediated Hh signaling
contributes to the functional patterning of the pituitary along the
anterior/posterior axis of the adenohypophysis. Our studies uncover a
speciﬁc temporal requirement for Hh/Gli signaling in the events of
pituitary induction, in the proper patterning of the two subdomains of
the adenohypophysis (the PD and PI), and in endocrine cell
differentiation. Since altered Hh signaling has been associated with
human adenomas (Vila et al., 2005), these results also suggest that
misregulated Gli1 and Gli2 function may be an important contributor
to common endocrine tumors.
Materials and methods
Wild type and mutant zebraﬁsh lines
Zebraﬁsh lines were maintained at the University of Massachu-
setts, Amherst Zebraﬁsh Facility. Embryos were incubated in embryoraising medium (ERM; 2 mMMgSO4, 2 mM KCl, 2 mM CaCL2, 0.5 mM
NaH2PO4, 5 mM NaCl) at 28.5 °C and staged as described (Kimmel et
al., 1995). Mutant lines used were you-too (yotty17) and detour (dtrts269)
(Karlstrom et al., 1999, 1996, 2003).
In situ hybridization
Antisense digoxigenin or ﬂuorescein labeled probes were gener-
ated against gli1 (Karlstrom et al., 2003), gli2a (Karlstrom et al., 1999),
gli2b (Ke et al., 2005), gli3 (Tyurina et al., 2005), nkx2.2a (Barth and
Wilson, 1995), ptc1 (Concordet et al., 1996), gh, tsh-β, prl, pomc
(Herzog et al., 2003), pitx3 (Dutta et al., 2005), and pax7 (Seo et al.,
1998). Whole mount in situ hybridization was performed as
previously described (Karlstrom et al., 1999). Gene expression patterns
were visualised using NBT/BCIP or Fast Red as the chromogenic
substrate (Roche Ltd, Basel, Switzerland). Following completion of the
staining reaction, embryos were cleared in 75% glycerol and examined
using DIC optics.
Cyclopamine treatments
Embryos were treated with 100 μM cyclopamine (Toronto
Chemical) (Incardona et al., 1998) by adding 10 μl of 10 mM stock
solution (in 95% EtOH) to 1 ml of ERM starting at the time points
indicated. Control embryos were treated simultaneously with an equal
volume (10 μl) of 95% EtOH (cyclopamine carrier) in 1 ml ERM.
Treatments were carried out in 12 well plates (n=30 embryos/well) at
28.5 °C. Embryos were dechorionated using 0.2 mg/ml pronase
(Sigma) and ﬁxed with 4% paraformaldehyde for in situ hybridization
analysis.
Early mRNA and MO injections
For shh mRNA injections the shh/T7TS plasmid (Ekker et al., 1995)
was linearized with BamH1 and transcribed using the Ambion
Message Machine T7 capped RNA transcription kit (Ambion Inc., TX,
USA). RNAwas diluted in 1× Danio solution (58 mM NaCl, 0.7 mM KCl,
0.4 mMMgSO4, 0.6 mM Ca(NO3)2, 5 mM Hepes, phenol red). Embryos
were injected with approximately 100 pg RNA at the 1–2 cell stage
using a pressure injector. Translation blocking morpholino oligonu-
cleotides (MO) were purchased from Gene Tools LLC (Philomath, OR).
Sequences were as follows: gli1MO: 5′CCGACACACCCGCTACACCCA-
CAGT-3′, gli2aMO: 5′-GGATGATGTAAAGTTCGTCAGTTGC-3′, gli2bMO:
5 ′-AGCTGGAACACCGGCCTCCATTCTG-3 ′ , and control MO:
CCTCTTACCTCAGTTACAATTTATA. All MOs were injected alone or in
combination at the 1–2 cell stage at a ﬁnal concentration of 4 ng.
Matched concentrations of standard control MOs were injected as a
control for MO toxicity. Injected embryos were cultured in ERM at
28.5 °C to 24–28 hpf or 48 hpf and ﬁxed with 4% paraformaldehyde
overnight at 4 °C. At least three independent experiments were
performed for each MO or combination of MOs. Replicates were
subsequently analyzed using the Chi Square test of homogeneity to
assess variation before the data were pooled. Statistical signiﬁcance
was veriﬁed using the Fisher Exact test. For endocrine cell counts, data
were obtained from a minimum of 15 larvae for each experimental
group. Statistical signiﬁcance was established using one-way ANOVA,
followed by Tukeys HSD test to identify signiﬁcant groupings.
Statistical computation was performed using software available on the
VassarStats website (http://faculty.vassar.edu/lowry/VassarStats.html).
Late morpholino injections
To investigate later functions of gli2a and gli2b, MOs or a cocktail of
at least 3 different antisense phosphorothioate-modiﬁed oligonucleo-
tides (S-oligos) (Sigma-Genosys, The Woodlands, TX) were injected at
the 17.5 hpf stage into the cavity just under the head and above the
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DNA phosphate backbone, which acts to stabilize the resulting DNA-
RNA hybrid and target the bound RNA for degradation by RNase H. The
sequences of the S-oligos were as follows; SGli2a-1: ggaTGATG-
TAAAGTTCGTCAGttgC, SGli2a-2: ctcCTTCAGATGCACATgggT, SGli2a-3:
ggcATGGTGCAAATGTGCTGatcT, SGli2a-4: ttaATATCTAGTTTGAACtacG.
80 μM total S-oligo or 4 ng of MO (gli1, gli2b, gli3) was injected in a
volume of 0.5 nl injection solution containing 6% lipofectamine
(Invitrogen, CA) and 0.1% phenol red.Fig. 1. Temporal requirement for Hh signaling in endocrine cell differentiation. (A) Cyclopam
(B) CyA treatments from 15 to 48 hpf severely reduced the number of prl (red) and anterior p
treatments from 20 to 48 hpf or 30 to 48 hpf had little effect on prl (red) and pomc (blue) cell n
(E) Control embryo treated with an equal volume of EtOH (CyA carrier) has normal num
expressing cells ectopically in the anterior brain and in the eye ﬁelds. Ectopic prl expressing
48 hpf eliminated gh expressing cells. (I, J) CyA treatments from either 20 to 48 or 30 to 48 h
gh expressing cells (arrows) were seen in 21% of shh mRNA injected embryos (n=42), altho
48 hpf eliminated tsh-β expressing cells. (N–P) tsh-β cell numbers were mildly reduced by Cy
(Q) Normal tsh-β cell numbers in a control embryo. (R) shhmRNA injections led to ectopic po
expressing endocrine genes in these experiments, ±standard error. Signiﬁcance was calculat
embryos were scored for each treatment. (A–R) Ventral views of 48 hpf embryos, anterior to t
of entire embryo and/or lim3 expression in the adenohyphysis at each corresponding age.Results
Distinct temporal requirements for Hh signaling in endocrine
cell differentiation
Our previous work demonstrated that Hh signaling is required
around 15 h post fertilization (hpf) for the induction of lim3
expression in the early placode, for placodal expression of the Hh
responsive gene nkx2.2a, and for differentiation of Prolactin (Prl)ine (CyA) treatments from 10 to 48 hpf largely eliminated prl and pomc expressing cells.
omc expressing cells, while posterior pomc cells were mildly reduced (arrow). (C, D) CyA
umbers in the placode, however hypothalamic (hy) pomc cells were reduced in number.
bers of prl and pomc expressing cells. (F) shh mRNA injections induced prl and pomc
cells were also seen in the PI (arrow). (G, H) CyA treatments from 10 to 48 hpf or 15 to
pf moderately reduced gh cell numbers. (K) gh expression in control embryo. (L) Ectopic
ugh the overall number of cells was largely unaffected. (M) CyA treatments from 10 to
A treatments from 15 to 48 and 20 to 48, but unaffected by treatments from 30 to 48 hpf.
pulations of tsh-β cells in the eye ﬁeld (arrows). (S) Graph showing the number of cells
ed for changes in cell number relative to controls. ⁎pb0.05; ⁎⁎pb0.01. A minimum of 20
he left. Scale bar: A–Q; 25 μm, R; 35 μm. Top is a time-line of CyA treatments with images
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types are spatially organized along the A/P axis of the adenohypo-
physis by 48 hpf, and their anterior/posterior position roughly
corresponds to their sensitivity to Hh signaling levels (Guner et al.,
2008). Further, endocrine cell types arise at different times, raising
the possibility that Hh could regulate endocrine cell differentiation
based both on time of differentiation and position in the placode.
Anterior cell types expressing pomc (corticotropes) and prl (lacto-
tropes) are the ﬁrst to differentiate at approximately 23 hpf (Herzog
et al., 2003; Liu et al., 2003) in the region that gives rise to the PD
(Guner et al., 2008). The pomc gene product is also expressed starting
about 25 hpf by posterior melanotropes that reside in the PI (Guner et
al., 2008; Liu et al., 2003). tsh-β expressing thyrotropes and gh
expressing somatotropes appear at approximately 40 and 42 hpf
respectively, and are located more medially. gh cells are found
exclusively in the caudal region of the PD, while tsh-β cells are
located in both the caudal PD and in the PI (Fig. 1, Guner et al., 2008).
To determine the temporal requirement for Hh signaling in the
induction of these endocrine cell types, we pharmacologically
blocked Hh signaling at different times using the alkaloid Hh
inhibitor cyclopamine (CyA) (Incardona et al., 1998) and counted
endocrine cell numbers at 48 hpf.Fig. 2. gli expression in the developing pituitary placode. (A, E, I) At 15 hpf (11 somites), gli1, g
the pituitary (arrows). (B, F, J) At 18 hpf (18 somites), gli1 gli2a, and gli2b expression all o
ectoderm but not in the developing pituitary placode (F, inset). (C, G, K) At 21 hpf (24 somite
inset). (D) At 30 hpf gli1 expression is maintained in the anterior region of the placode,
(arrowhead).(H, L) At 30 hpf gli2a and gli2b are expressed posteriorly in the PI (arrowheads),
Lateral views of the ventral forebrain, anterior to the left, eyes removed. Red dashed lines sh
Scale bar: A–C, E–G, I–K; 100 μm, D, H, L; 30 μm.As shown previously, blocking Hh signaling starting prior to
somitogenesis (10 hpf) eliminated all hormone secreting cells (Figs.
1A, G, M), consistent with a role for Hh in inducing the entire placode
(Sbrogna et al., 2003). Blocking Hh signaling starting at mid-
somitogenesis stages (15 hpf) led to amajor reduction in prl expressing
lactotropes (Fig. 1B), while treatments after this time point did not
signiﬁcantly affect lactotrope numbers (Figs. 1C, D). Consistent with a
role for Hh in lactotrope cell differentiation, overexpression of Hh led
to an increase in Prl cell numbers in 100%of embryos examined (n=83),
with ectopic cells residing at the anterior edge of the embryo, aswell as
in the eye (Fig.1F). The fact that ectopic endocrine cells are found in the
area of the lens supports the idea that lens and pituitary precursors are
part of an equivalence domain at the ANR (Dutta et al., 2005), and
further suggests that Hh signaling can cause lens precursors to trans-
differentiate as endocrine cells.
Similar to lactotropes (prl), pomc expressing corticoptropes failed
to differentiate in the PD when Hh signaling was blocked starting at
15 hpf (Fig. 1B). Unlike lactotropes, corticotrope differentiation was
also blocked by treatments starting at 20 hpf (Fig. 1C), showing a
continued dependence on Hh signaling that lasts through 30 hpf.
Posterior pomc expressing melanotropes were slightly reduced by
all CyA treatments (Figs. 1A–D), indicating Hh signaling plays a moreli2a and gli2b are all expressed in epidermal cells at the ANR of the embryo that will form
verlap with pitx3 expression (B inset) at the ANR. gli3 is expressed in adjacent neural
s) gli1, gli2a, and gli2b expression is continuous across the ANR and gli3 is still absent (G,
the pars distalis (arrow), but is reduced in the posterior region, the pars intermedia
but not in the pars distalis (arrows). (A–C, E–G, I–K) Dorsal views, anterior left. (D, H, L)
ow border between developing placodal cells and neural ectoderm of the diencephalon.
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injections expanded pomc expressing cells across the anterior
forebrain and into the eye region (92%, n=73), similar to prl cells
(Fig. 1F).
Like anteriorly positioned corticotropes, Gh secreting somato-
tropes were very sensitive to the loss of Hh signaling throughout the
ﬁrst two days of development. Blocking Hh starting at either 10 or
15 hpf completely eliminated gh expressing cells (Figs. 1G, H).
Blocking Hh starting at 20 hpf eliminated most gh cells (Fig. 3I),
while blocking Hh at later timepoints (30–48 h) resulted in
approximately half the number of cells (Fig. 3J). Thus differentiation
of somatotropes requires Hh signals over a much broader time
window, at least from 10 to 30 hpf. Hh overexpression had a minor
effect on gh expressing somatotropes, with 21% of shh mRNA injected
embryos having ectopic cells (n=42; Fig. 1L). In contrast to
lactotropes (prl) and somatotropes (gh), tsh-β secreting thyrotropes
were only mildly reduced by the loss of Hh signaling from 10 to
30 hpf (Figs. 1N–P). Further, overexpression of Shh did not alter the
overall number of thyrotropes, although ectopic tsh-β expressing
cells were often found in the eye region (62%, n=37; Fig. 1R).
Together, our data show that thyrotrope and melanotrope differen-
tiation is largely independent of Hh signaling, while differentiation of
somatropes, lactropes, and corticotropes requires Hh signaling. The
time that Hh signaling is required varies for each endocrine cell type
and may correspond to the time when hormone-speciﬁc precursor
cells ﬁrst differentiate.Fig. 3. Gli1, Gli2a, and Gli2b contribute to the Hh response in the pituitary. (A) At 30 hpf nkx2
in both the PD and PI. (B) In dtr(gli1)mutants, nkx2.2a expression is reduced in the PD (arrow
gli2a morpholinos (MOs) into wildtype embryos led to a posterior expansion of nkx2.2a an
nkx2.2a expression in the adenohypophysis, but did not further reduce lim3 expression (
nkx2.2a and lim3 expression (arrows). (F) gli2b MO injections into dtr(gli1) mutants elimi
(inset). (G) Co-injection of gli2a and gli2b MOs led to posterior expansion of nkx2.2a and
expression and reduced lim3 expression. (I) Dominant repressor forms of Gli2a encoded by
(gli2DR) rescued nkx2.2a expression (arrowhead), with expression resembling that seen in dtr
to the left, eyes removed. Scale bar: A–J; 30 μm, insets in panels A–H; 40 μm.Expression of gli genes in the developing adenohypophysis
Given the temporally distinct roles for Hh signaling in adenohypo-
physis development, and the demonstrated role for gli genes in pituitary
development shown in the zebraﬁsh dtr(gli1) and yot(gli2) mutants
(Guner et al., 2008; Karlstrom et al., 1999; Sbrogna et al., 2003), we next
wondered which gli gene or genes were expressed in the developing
placode. We carefully examined the onset of gli1, gli2a, gli2b and gli3
expression during induction of the adenohypophysis at the anterior
neural ridge (ANR) as well as later when the PD and PI form along the
anterior/posterior axis of the placode. Expression of the Hh responsive
genes ptc1 and nkx2.2a in pre-placodal cells at the ANR at 14.5 hpf (11
somites) indicates that these cells directly respond to Hh signals prior to
the onset of the pituitary speciﬁc gene lim3 (Dutta et al., 2005; Sbrogna
et al., 2003). We found that gli1 (Figs. 2A, B), gli2a (Figs. 2E, F), and gli2b
(Figs. 2I, J), but not gli3 (Fig. 2F inset, data not shown)were expressed in
the pre-placodal cells at the ANR at the time that they express the Shh
receptor ptc1, and just prior to the expression of the pituitary speciﬁc
gene lim3 (Fig. 2B inset, Sbrogna et al., 2003), suggesting these three gli
genes might be responsible for interpreting the initial Hh signals that
induce pituitary gene expression in pre-placodal cells at the ANR.
gli1, gli2a and gli2b continued to be expressed in cells spanning the
anterior midline of the neural plate until approximately 21 hpf, when
gli1 expression was downregulated in medial cells and more strongly
expressed in lateral cells (Fig. 2C). At 21 hpf, gli2a and gli2b were
expressed both medially and laterally at the ANR (Figs. 2G, K). By.2a is expressed in the PD (arrowhead) but not in the PI (arrow). lim3 (inset) is expressed
head) and lim3 expression is reduced, indicating a smaller placode (inset). (C) Injecting
d lim3 expression (arrows). (D) Injecting gli2a MOs into dtr(gli1) mutants eliminated
inset). (E) Injecting gli2b MOs into wildtype embryos led to a posterior expansion of
nated nkx2.2a expression in the placode, but did not further reduce lim3 expression
lim3 expression (arrows). (H) Co-injection of gli2a and gli2b MOs eliminated nkx2.2a
the yot locus eliminate nkx2.2a expression in the PD. (J) gli2a MO injections into yot
(gli1)mutants (compare to panel B). (A–J) Lateral views of the ventral forebrain, anterior
Table 1
Gli2a and Gli2b morpholino injections into dtr(gli1−/−)
Assay Injected
cross
Morpholino Expression n
Expansion Reduction Absent Wildtype
nkx2.2 dtr(gli1−/−) 4 ng control MO – 95% (20) 5% (1) – 21
8 ng control MO – 93% (13) 7% (1) – 14
4 ng Gli2a MO – 37% (6) 63% (10)a – 16
4 ng Gli2b MO – 54% (7) 46% (6)b – 13
4 ng Gli2a+Gli2b MO – 10% (3) 90% (27)c,d – 30
WT sibs 4 ng control MO – – – 100% (33) 33
8 ng control MO – – – 100% (32) 32
4 ng Gli2a MO 60% (34) – – 40% (23) 57
4 ng Gli2b MO 47% (22) 8% (4) – 45% (21) 47
4 ng Gli2a+Gli2b MO 52% (35) 28% (19) – 20% (13) 67
lim3 dtr(gli1−/−) 4 ng control MO – 100% (9) – – 9
8 ng control MO – 100% (7) – – 7
4 ng Gli2a MO – 100% (17) – – 17
4 ng Gli2b MO – 100% (13) – – 13
4 ng Gli2a+Gli2b MO – 100% (13) – – 13
WT sibs 4 ng control MO – – – 100% (30) 30
8 ng control MO – – – 100% (27) 27
4 ng Gli2a MO – 23% (11)b – 77% (36) 47
4 ng Gli2b MO – 24% (8)b – 76% (26) 34
4 ng Gli2a+Gli2b MO – 38% (13)e – 62% (21) 34
Numbers in parentheses indicate the number of embryos scored.
a Signiﬁcantly different (pb0.001) from 4 ng control MO injected embryos.
b Signiﬁcantly different (pb0.01) from 4 ng control MO injected embryos.
c Signiﬁcantly different (pb0.05) from 4 ng Gli2a MO injected embryos.
d Signiﬁcantly different (pb0.01) from 4 ng Gli2b MO injected embryos.
e Signiﬁcantly different (pb0.001) from 8 ng control MO injected embryos.
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complementary, with gli1 expressed anteriorly in the PD (Fig. 2D)
and gli2a and gli2b expressed posteriorly in the PI (Figs. 2H, L). This
suggests that Gli1 and Gli2a and Gli2b may have different functions as
the placode becomes patterned along the anterior–posterior axis and
as these two distinct subdomains form (Guner et al., 2008).
Overlapping functions for Gli1, Gli2a and Gli2b during adenohypophysis
induction
To begin to uncover the Gli transcriptional response “code” that
interprets Hh signals during adenohypophysis induction we next
blocked Gli function either genetically or by injection of antisense
morpholino oligonucleotides. While the adenohypophysis is comple-
tely absent in zebraﬁsh mutants lacking Smoothened function (smo
mutants) and is extremely reduced in yot(gli2aDR) mutant embryos
(Sbrogna et al., 2003), it is only slightly reduced in size in dtr(gli1)
mutants. In addition, low-level expression of the Hh responsive gene
nkx2.2a remains in the anterior region, the PD (Fig. 3B, Guner et al.,
2008; Sbrogna et al., 2003) in the absence of Gli1 function. This
strongly suggests that other Gli proteins positively mediate Hh
signaling during placode induction. To determine which Gli proteins
perform this activator function, we injected translation-blocking gli2a
and/or gli2bmorpholinos into dtr(gli1)mutant embryos. Knock-down
of either Gli2a or Gli2b function was sufﬁcient to abolish residual
nkx2.2a expression in a signiﬁcant proportion of dtr(gli1) mutants
(Figs. 3D, F, Table 1). An additional increase in the penetrance of this
phenotype was observed when both gli2a and gli2b MOs were co-Fig. 4. Gli function in endocrine cell determination. (A–D) Normal expression of prl, gh,
adenohypophysis is outlined. (E–H) Loss of Gli1 function either by gli1MO injection or in dtr
eliminated gh (F) expressing cells. tsh-β (G) and posterior pomc cells (H) were relatively unaff
tsh-β (K) populations, slightly reduced anterior pomc (L) and gh (J) expressing cells, and had l
expand in response to reduced Gli2b function (L). Injection of gli2a MOs also expanded prl c
and Gli2b function further expanded prl populations (M), reduced anterior pomc cells (P) and
of Gli1 in combination with loss of Gli2a and Gli2b eliminated the expansion of prl cells seen
slightly expanded tsh-β cell numbers (S). (U) Graph showing cell numbers across all Gli los
shading shows the results following injection of gli2 (2a and/or 2b) MOs in awild type backgr
MOs in a gli1 loss-of-function background. Scale bar: A–T; 25 μm.injected into dtr mutants (Fig. 3H, Table 1). This indicates that either
Gli2a or Gli2b can activate the low level of nkx2.2a expression seen in
the absence of Gli1 function. Reducing Gli2a and/or Gli2b function in
wild type embryos did not perceptably reduce nkx2.2a expression
(Figs. 3C, E, G). Interestingly, loss of Gli2a and/or Gli2b function caused
an expansion of nkx2.2a into the posterior region of the placode (the
PI), as well as a posterior expansion of lim3 expression (Figs. 3E, G).
This points to an additional repressor role for both the Gli2a and Gli2b
proteins. gli3MO injections did not affect pituitary development (data
not shown). Together these data suggest that a threshold level of Gli
activator function is needed for normal nkx2.2a expression.While Gli1
appears to mediate a majority of this activator function, Gli2a and
Gli2b can also contribute as activators of the Hh response.
Further evidence that Gli1 is the major Shh activator during
placode induction, with Gli2a and Gli2b playing minor activator roles,
came from experiments in which the dominant repressor form of
Gli2a expressed by the yot(gli2aDR) mutant was reduced using gli2a
morpholino injections. Injecting gli2a MOs into yot(gli2aDR) mutant
embryos partially rescued nkx2.2a expression in the pituitary (Fig. 3J),
with nkx2.2a expression being similar to that seen in dtr(gli1)mutants
(Fig. 3B). Since only truncated Gli2a proteins are made in yot(gli2aDR)
mutants, these gli2a MO injected yot(gli2aDR) mutant embryos lack
any possible Gli2a activator function and thus any activator function
must be mediated by Gli1 and/or Gli2b. Further, since yot mutants
express the Gli2aDR protein in the same cells in which normal Gli2a is
expressed in wild type embryos (R.O.K unpublished data), this rescue
suggests that the Gli2a repressor normally functions in the same cells
as activator Gli proteins, implying a balance of Gli activator andtsh-β and pomc in the adenohypophysis at 48 hpf (ventral view, anterior left). The
(gli1−/−) mutants (not shown) reduced prl (E) and anterior pomc (H) expressing cells and
ected by loss of Gli1 function. (I–L) In contrast, loss of Gli2b function expanded prl (I) and
ittle effect on posterior pomc cells (L). Hypothalamic (hy) pomc populations appeared to
ells posteriorly (I, inset) in 40% of embryos examined. (M–P) Simultaneous loss of Gli2a
had little effect on gh (N), tsh-β (O) and posterior pomc (P) expressing cells. (Q–T) Loss
following Gli2b MO injection (Q), further reduced gh (R) and anterior pomc cells (T), and
s-of-function experiments, represented as percentage of wild type cell numbers. Gray
ound. Black shading shows the results obtained following injection of gli2 (2a and/or 2b)
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Interestingly, in clutches obtained from crosses between two yot(+/−)
adults, gli2b MO injection led to a reduction in nkx2.2a expression in
58% of embryos. Subsequent genotyping conﬁrmed these embryos to
be yot+/− heterozygotes (n=15, data not shown). This suggests thatGli2b contributes aweak activator function that is uncoveredwhen Gli
activator function is attenuated by the presence of one copy of the
gli2a dominant repressor gene. Together, these data show that overall
levels of Gli1, Gli2a and Gli2b activator function are important for the
proper Hh transcriptional response in the pituitary.
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Having demonstrated overlapping activator functions for Gli1,
Gli2a and Gli2b during Hh-mediated induction of the adenohypo-
physis, we next sought to determine how each of the Gli genes
contributes to endocrine cell differentiation and thus the functional
patterning of the pituitary. To dissect overlapping and unique roles for
each of the Gli genes, we analyzed the expression of prl, pomc, gh and
tsh-β in embryos injected with different gli morpholinos.
Loss of Gli1 function, either in dtr(gli1)mutants or gli1MO injected
embryos, led to the loss or reduction of anterior pomc (pomc-a), prl
and gh expressing cells (Figs. 4E, F, H, U, Table 2, Sbrogna et al., 2003),
demonstrating the requirement for Gli1 in the differentiation of
somatotropes as well as the most anterior endocrine cell populations
(lactotropes and corticotropes) of the PD. In contrast, loss of Gli1 had
little effect on thyrotropes (tsh-β) or posterior pomc (pomc-p)
expressing melanotropes (msh) (Figs. 4G, H, U), consistent with a
minimal role for Gli-mediated Hh signaling in PI differentiation
(Guner et al., 2008).
Loss of either Gli2a or Gli2b function moderately reduced the
number of anterior pomc expressing cells (corticotropes), an effect
that was enhanced when both Gli2a and Gli2b were reduced (Figs. 4L,
P, U). This suggests a minor activator role for both of these Gli proteins
in this cell population. No signiﬁcant difference was observed in the
number of prl, gh, tsh-β, and pomc-p populations following knock-
down of Gli2a function (Fig. 4U, Table 2), however prl cells were
mispositioned posteriorly in 40% of embryos examined (n=20, Fig. 4I)
suggesting that Gli2a may act to restrict anterior fates from the
posterior region. In contrast, loss of Gli2b function led to a signiﬁcant
increase in prl and tsh-β expressing cells, suggesting that Gli2b
normally functions to repress differentiation of these cell types (Figs.
4I, K, U, Table 2). Coinjection of gli2a and gli2b MOs did not increase
prl cell numbers beyond that observed following knock-down of
Gli2b alone (Figs. 4M, U, Table 2), indicating Gli2b but not Gli2a
negatively regulates prl cell numbers. These results point to distinct
functions for the different gli genes in different endocrine populations.
Given this complex code of Gli function, we next wondered
whether Gli1 activator function was working to overcome Gli2
repressor function, similar to the situation in the limb, where loss of
Hh function can be rescued by the simultaneous loss of Gli3 repressor
(te Welscher et al., 2002). To determine how Gli1 interacts with Gli2a
and Gli2b in the placode, we coinjected gli1 MOs with gli2a and/or
gli2b MOs. Simultaneous knock-down of all three Gli genes (gli1,
gli2a and gli2b) led to a signiﬁcant reduction in all endocrine cell
types, with the exception of tsh-β cells (Figs. 4Q–U). This reduction is
similar to, but less severe than that seen in yot(gli2DR)mutants, which
lack most endocrine cell types (data not shown, Sbrogna et al., 2003).Table 2
Endocrine cell counts following single and combinatorial Gli MO knock-down
WT Gli2
pomc-a WT 17.18±1.03 (17) 1
Gli1 MO 9.35±0.95 (20)a 9.7
prl WT 14.4±0.63 (20) 14.7
Gli1 MO 8.95±0.41 (20)a 6.5
gh WT 6.24±0.45 (21) 5.8
Gli1 MO 2.05±0.32 (21)a 0.7
tsh-β WT 12.45±0.62 (20) 12.0
Gli1 MO 11.3±0.54 920) 9.5
pomc-p WT 7.53±0.61 (17) 8.
Gli1 MO 8.2±0.58 (20) 7.8
Numbers in parentheses indicate the number of embryos scored.
a Signiﬁcantly different (pb0.01) from control MO injected embryos.
b Signiﬁcantly different (pb0.01) from gli1 MO injected embryos.
c Signiﬁcantly different (pb0.05) from gli1 MO injected embryos.
d Signiﬁcantly different (pb0.05) from control MO injected embryos.Notably, loss of Gli2a and/or Gli2b function did not rescue the loss of
cells seen in gli1 MO injected embryos, indicating Gli1 function does
not merely act to counter Gli2 repressor roles. Loss of Gli1 function did
eliminate the expansion of prl and tsh-β populations seen following
gli2b MO injection (Figs. 4Q, S, U), indicating that increases in these
cell numbers require Gli1 activity. While tsh-β cells are the least
responsive to Gli manipulations, a balance of Gli repressor and
activator function does appear to be important for regulating correct
tsh-β cell numbers. Co-injection of gli1, gli2a, and gli2b MOs
eliminated the increase in cell numbers seen when gli2b MOs were
injected alone (Figs. 4S, U), restoring tsh-β cell numbers to wild type
levels (Table 2).
In summary, our loss of function studies reveal a complex code of
Gli function in the differentiation of endocrine cells that helps regulate
endocrine cell numbers. Gli1 appears to be the major activator of Hh-
mediated endocrine cell differentiation, with Gli2a and Gli2b also
playing minor activator roles for some cell types. Gli1 is required for
differentiation of somatotropes (gh) and corticotropes (pomc-a) in the
PD, but does not appear to play a role in differentiation of medially
located thyrotropes (tsh-β) or posteriorly located melanotropes
(pomc-p). This is consistent with the requirement for high levels of
Hh activation in PD formation but not PI formation (Guner et al.,
2008). Gli2b seems to act as a repressor of prl and tsh-β cell
differentiation, and may do so by repressing Gli1 activator function.
Distinct late functions for Gli1 and Gli2 in pituitary patterning
We next wondered how the different activator and repressor
functions of Gli1 and Gli2 might be regulated. In the zebraﬁsh CNS,
distinct functions for Gli3 appear to be temporally regulated, with Gli3
activating the Hh response early in development, and then repressing
Hh target genes at later times (Tyurina et al., 2005). Based on the
changing expression pattern of gli2a and gli2b in the placode (Fig. 2),
we hypothesized that these proteins might function as activators of a
Hh transcriptional response during the early induction phase of
placode development, and then switch to repressors of the Hh
response as the placode becomes functionally patterned. To test this
hypothesis we injected antisense oligonucleotides (thioester contain-
ing S-oligos) or MOs near the pituitary placode at 17.5 hpf (Fig. 5A),
after Hh-mediated induction of pituitary speciﬁc genes at the ANR had
occurred at approximately 15 hpf (Sbrogna et al., 2003). We then
assayed injected embryos at 40 hpf to determine the effects on the
differentiation of anterior lactotropes (prl) and corticotropes (pomc-a)
as well as posterior melanotropes (pomc-p).
To ﬁrst prove that late antisense oligonucleotide injections could
effectively block late gli function, we injected a well characterized gli3
MO into the spinal cord at late somitogenesis stages (Tyurina et al.,a MO Gli2b MO Gli2a+Gli2b MO
4±0.98 (20) 14.95±1.12 (21) 9.9±0.71 (21)a
5±0.88 (20)a 5.76±1.54 (21)a 6.69±1.25 (16)a
5±0.74 (20) 19.14±0.74 (21)a 20.15±1.23 (20)a, b
2±0.46 (21)a, c 9.4±0.61 (20)a 5.7±0.59 (20)a, c
5±0.73(20) 4.2±0.36 (20)d 1.57±0.4 (23)a
5±0.23 (20)a 1.1±0.36 (20)a 0.55±0.19 (22)a, c
5±0.87 (20) 17.48±0.82 (21)a 13.14±1.14 (21)
7±0.69 (21)d 13.15±1.24 (20) 13.62±1.03 (21)
2±0.54 (20) 7.95±0.5 (21) 6.86±0.46 (21)
5±0.6 (20) 6.86±0.46 (21) 7.05±0.47 (16)b,d
Fig. 5. Distinct roles for gli genes in pituitary patterning. (A) To block Gli function at later
time periods, 17.5 hpf embryos were placed in agarose wells and antisense
oligonucleotides were injected into the space below the developing head. (B, C) Late
injection of gli3 MOs led to an expansion of ptc1 into the dorsal spinal cord (arrows,
spinal cord shown in cross section), consistent with a loss of Gli3 repressor function.
This control experiment shows that Gli activity can be reduced by late MO injections.
(D) Normal expression of nkx2.2a and prl (inset, ventral view) following control MO
injection at 17.5 hpf. (E) Injection of gli1 MOs reduced anterior expression of both
nkx2.2a and prl (inset). (F, G) Late injections of gli2a or gli2b antisense MOs or S-oligos
led to a posterior expansion of nkx2.2a expression in the placode (arrowheads). (H)
Lateral view of the ventral forebrain showing normal prl (blue label) and pomc (red)
expression in the placode of control MO injected embryos. (I, J) Late injection of gli2a or
gli2b MOs led to ectopic prl expression in the posterior region of the placode
(arrowheads), and to a reduction in posterior pomc expression. (D–J) show 40 hpf
embryos, anterior to the left. Black lines show the anterior–posterior extent of the
placode with the arrowhead pointing to the most posterior extent of gene expression
(nkx2.2a or prl). Dotted lines in D, E insets outline the adenohypophysis. Scale bar: B, C;
20 μm, D-J; 35 μm.
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target gene ptc1 into the dorsal spinal cord (Fig. 5C), consistent with
loss of Gli3 repressor function at this time (Tyurina et al., 2005).
Injection of gli1 MOs ventral to the forebrain at 17.5 hpf reduced
both nkx2.2a and prl expression in the pituitary placode, with both
domains being restricted to the mid region of the placode (Fig. 5E).
These results show that Gli1 continues to activate the Hh response
during later pituitary development, and further conﬁrm that late MO
injection can affect gene function. We next injected gli2 MOs or S-
oligos at 17.5 hpf. In contrast to Gli1, late loss of Gli2a function led to an
expansion of nkx2.2a expression into the posterior region of the
adenohypophysis (Fig. 5F). Loss of late Gli2a function also led to an
expansion of lactotropes (prl) into the posterior region of the placode
(Fig. 5I) as was seen following early gli2a MO injections (Fig. 4I).
Similar to gli2a, injection of gli2b MOs caused an expansion of both
nkx2.2a and prl expression into the posterior placode (Figs. 5G, J).
This expansion of the anterior marker nkx2.2a and of anterior cell
types indicates that Gli2a and Gli2b function to repress Hh-mediated
differentiation of anterior cell types in the posterior region of the
pituitary.Discussion
Gli transcriptional response code is required for adenohypophysis
induction and formation of the PD and PI
The adult adenohypophysis is composed of two subdomains, the
anterior pars distalis (PD) and the posterior pars intermedia (PI), a
structural division that is conserved across vertebrate species. In
zebraﬁsh, the PD forms closer to the anterior source of Shh in the CNS
while the PI forms close to a posterior source of Fgf3 (Fig. 6B, Guner et
al., 2008; Liu et al., 2008). Recent evidence from our lab suggests that
graded Shh and Fgf signaling from the CNS helps establish these two
subdomains from the earliest stages of placode development (Guner
et al., 2008). Here we focus on how graded Hh signals are interpreted
by cells in the pituitary placode. In the CNS, graded Hh signals are
converted into graded levels of Gli transcriptional activator and
repressor function (Jacob and Briscoe, 2003; Stamataki et al., 2005)
that then inﬂuence the transcriptional program in cells to establish
different domains of gene expression along the dorsal/ventral axis. We
show that a complex code of Gli activator and repressor function is
similarly required for patterning of the adenohypophysis. Gli1, Gli2a
and Gli2b mediate a Hh transcriptional response that is required for
normal induction of the placode and for establishing proper gene
expression domains that deﬁne the PD and PI.
Initially gli1, gli2a and gli2b are expressed in pitx3-positive cells
that span the ANR in a region that can form either lens or
adenohypophysis (Fig. 6A, Dutta et al., 2005). Midline pre-placodal
cells that contribute to the adenohypophysis begin to express nkx2.2a
and ptc1 just prior to the initiation of the pituitary speciﬁc gene lim3
(lhx3), indicating they are responding to Hh signals. At this early stage
of placode induction, Gli1, Gli2a, and Gli2b all have overlapping roles
as activators of this Hh response, with Gli1 acting as the primary
activator and Gli2a and Gli2b providing more minor activator roles
(Fig. 6A). Unlike the situation in the CNS, gli3 does not appear to be
expressed in this Hh responsive ﬁeld, and loss of Gli3 function had no
effect on pituitary development.
As placodal cells coalesce toward themidline andmove ventrally, the
central/anterior region remains closer to the source of Hh and continues
to express nkx2.2a, indicating a continued maximal Hh response (Fig.
6B). Posterior regions becomemore distant from the source of Shh, lose
nkx2.2a expression and begin to express pax7, a gene repressed by Hh
signals (Fig. 6B, Briscoe et al., 2000;Guner et al., 2008). This suggests that
as posterior placodal cells move away from the CNS source of Shh,
signaling levels fall below a critical threshold and a distinct transcrip-
tional response is initiated posteriorly. The time of exposure to Shhmay
also contribute to this differential transcriptional response, as anterior
cells experience Shh signals over a longer time period than posterior
cells (Dessaud et al., 2007). In either case, this differential Hh
transcriptional response may mark the ﬁrst division of the adenohypo-
physis into two domains that form the PD and PI.
During these placodal cell movements, Gli1 (also a transcriptional
target of Hh signaling) is maintained in the anterior region (PD) and
continues to positively mediate the response to Hh in the PD. In
contrast, Gli2a and Gli2b become restricted to the PI. At these times,
Gli2a and Gli2b function may be necessary to establish and maintain a
balance of Gli activator and repressor functions, as indicated by the
expansion of nkx2.2a expression into the PI following loss of Gli2b.
Partial rescue of nkx2.2a expression following gli2a MO injection into
yot(gli2aDR)mutant embryos suggests that a balance of Gli1 activator
and Gli2 repressor function may initially act within the same cells to
initiate the formation of distinct cell types (dashed lines in Fig. 6B).
Our late MO injections indicate that this spatially distinct Gli code
(Gli1 activator anteriorly, Gli2a and Gli2b repressor posteriorly) is then
important for maintaining proper gene expression in the PD and PI.
This later role of Gli2a and Gli2b in repressing Hh signaling in the PI is
analagous to the role played by Gli3 in the dorsal spinal cord (Jacob
Fig. 6. The Gli response code to Hh signaling during adenohypophysis development. (A) Schematic dorsal view of the head region at 15 hpf when pituitary speciﬁc genes are ﬁrst
induced at the anterior neural ridge (ANR). gli1, gli2a, and gli2b are expressed in the entire pitx3 positive domain (red and green regions). Shh signals (black) from the CNS induce
nkx2.2a and lim3 expression in the central domain (red), which gives rise to the adenohypophysis (ah). At this stage Gli1, Gli2a and Gli2b function together to activate the Hh response
in these cells. Medial cells coalesce toward the midline and migrate ventrally as the placode forms (arrows). (B) Lateral schematic views of the adenohypophysis at 30 and 42 hpf.
Ventral movements bring the placode ventral/posterior to the source of Shh (black) in the hypothalamus. Fgf3 (purple) is expressed posterior to the placode. gli1 expression becomes
restricted anteriorly to the PD (red) while gli2a and gli2b expression become restricted to the PI (orange). This change in expression coincides with a change in Gli function. Gli1
continues to function as an activator of Hh responsive genes, while Gli2a and Gli2b switch to repressors of the Hh response. Gli genes also play distinct roles in endocrine cell
differentiation throughout these stages.
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which Hh can act and helping to establish distinct precursor
populations in different anterior/posterior positions in the placode.
In this case, this spatially distinct transcriptional response may also
help establish a border that results in formation of the PD and PI.
Gli/Hh signaling regulates endocrine cell number and position
Different endocrine cell types appear over a wide range of
developmental stages and at distinct positions within the placode. The
fact that the timing, position, andnumber of each endocrine cell type are
highly reproducible between individual zebraﬁsh embryos suggests a
tight regulation of cell differentiation that may impact on endocrine
function. Given the established role for Hh as amorphogen in the spinal
cord (reviewed in Ingham and McMahon, 2001) and the position of Hh
dependent endocrine cells relative to the source of Hh, it is possible that
Hh is similarly acting as a morphogen to guide differentiation of
endocrine precursor cells in the adenohypophysis (Guner et al., 2008).
Using cyclopamine to inhibit Hh signaling at different times in placode
development, we uncovered distinct temporal requirements for Hh in
endocrine cell differentiation, suggesting that changing positions of
endocrine precursors relative to the source of Hhmayalso inﬂuence this
process. Gain of Hh function greatly expanded anterior cell types,
suggesting that Hh levels regulate differentiation and/or proliferation of
some but not all endocrine cell types.
Consistent with this differential role for Hh in endocrine cell
differentiation, different gli genes are required to establish the correct
pattern and number of endocrine cell types within each subdomain of
the pituitary. Gli1 is required for normal numbers of somatotropes
(gh), lactotropes (prl) and anterior corticotropes (pomc-a) in the PD.
Gli2a and Gli2b together are required for normal numbers of pomc-a
and gh cells in the PD, and for pomc expressing cells in the PI. Gli2b
also plays a role in restricting prl and tsh-β cell numbers, with loss of
Gli2b function leading to a dramatic increase in these cell types. This
expansion in cell numbers is dependent on Gli1 function, consistent
with a role for Gli2b as a repressor of Hh-mediated cell differentiation
at later time points. Knockdown of Gli2a and Gli2b affected endocrine
cell position in both the pituitary and hypothalamus, consistent with
pattering roles in both tissues.
Intriguingly, two cell types that reside in the middle region of the
pituitary, somatotropes (gh) and thyrotropes (tsh-β), have very different
requirements for Hh signals. Somatotropes, like lactotropes, require Hh/Gli signals to differentiate, while thyrotropes do not. On the surface, this
would argue against a gradient model for Hh and suggest that the
position of a differentiating cell relative to the source of Hh does not
affect precursor identity. However, it was recently reported that teleost
somatotropes and lactotropes may arise from a common precursor cell
called themammosomatotrope that secretes bothGh and Prl (Villaplana
et al., 2000). If a common precursor for somatotropes and lactotropes
were located near the source of Hh, with later cell migration leading to
ﬁnal endocrine cell position in the adenohypophysis, this could explain
the similar sensitivity of these two cell types to Hh signals and ﬁt with a
morphogen model. It will be necessary to identify progenitor speciﬁc
markers to distinguish between these possibilities.
Downstream of the Gli code
Howmight theGli transcription factors regulate the relative numbers
of endocrine cell types in the pituitary? Clearly the combination of Gli
activator and repressor functions must result in unique transcriptional
programs that differ across the placode. One candidate for a downstream
target of this differential Gli code is Notch signaling. Though not required
for initial placode formation, Notch appears to act on early placodal cells
to promote thedifferentiation of somatotropes (gh), corticotropes (pomc-
a) and melanotropes (pomc-p), and restrict differentiation of lactotropes
(prl), thyrotropes (tsh-β) and gonadotropes (Dutta et al., 2008). Based on
these ﬁndings, it was proposed that long range signals, such as Hh and
FGF, act early to induce and help pattern the early pituitary placode,
establishing a series of regionally distinct subdomains along the A/P axis.
Notch signaling appears to act within these subdomains to regulate
choices between cell fates, and thus regulate the numbers of hormone
cell types, presumably by lateral inhibition.
Interestingly, loss of Notch function was found to result in an
increased number of lactotropes (prl) and thyrotropes (tsh-β), similar
to the situation observed following knock down of Gli2b function.
Dutta et al., (2008) suggest that lactotropes and thyrotropes constitute
the primary cell fates within the placode and that loss of Notch
function therefore leads to an increase in lactotropes and a
concomitant decrease in corticotropes (the secondary cell fate) in
the PD. While these results are consistent with a model in which Hh/
Gli signaling acts upstream of Notch in the speciﬁcation of hormone
cell types, they do not shed light on the loss of anterior cell types (both
lactotropes and corticotropes) observed following knock-down of Gli1
function. An alternative explanation may be that the speciﬁc Gli code
153C.A. Devine et al. / Developmental Biology 326 (2009) 143–154directs the expression of precursor-speciﬁc transcription factors that
in turn deﬁne different precursor populations upon which Notch will
act. Establishing the transcriptional output of each of the Gli
transcription factors will therefore be necessary to identify key
determinants for these progenitor populations and understand the
coordinated action of both long-range and short-range signals in
speciﬁcation of endocrine cell fate in the pituitary.
Hh/Gli signaling and pituitary adenomas
Misregulation of Hh/Gli signaling has been implicated in several
developmental disorders that affect the pituitary, including Holopro-
sencephaly and Pallister–Hall syndrome (Bose et al., 2002; Kalff-Suske
et al., 1999; Ming et al., 1998; Ruiz i Altaba, 1999). As with most
developmentally important signaling systems, misregulation of Hh
signals post embryonically is associated with cancer, including
medulloblastoma and basal cell carcinoma (Ruiz i Altaba et al.,
2004; Scott, 2003). Hh misregulation has also been linked to common
pituitary adenomas, with cell culture data suggesting that Hh
signalling may negatively regulate endocrine cell proliferation in
these tumors (Vila et al., 2005). Pituitary adenomas affect up to 17% of
the population (Ezzat et al., 2004), making these among the most
common human tumors. Despite this prevalence in the population,
the molecular mechanisms underlying the occurrence of pituitary
adenomas are poorly understood. Here we provide data suggesting
speciﬁc roles for Gli genes in zebraﬁsh endocrine cell differentiation,
work that should inform studies into the mechanisms that cause the
misregulation of endocrine cell proliferation during pituitary tumor-
ogenesis in humans. Understanding how Gli proteins mediate Hh
signaling during normal development may thus shed light on ways to
treat and hopefully prevent some of these tumors.
Acknowledgments
Wewould like to thank Jeanne Thomas for the technical assistance,
Judy Bennett for the ﬁsh care, and members of the Karlstrom lab for
their comments on the manuscript. This work was supported by NIH
grants NS039994 and HD044929.
References
Aza-Blanc, P., Ramirez-Weber, F.A., Laget, M.P., Schwartz, C., Kornberg, T.B., 1997.
Proteolysis that is inhibited by hedgehog targets Cubitus interruptus protein to the
nucleus and converts it to a repressor. Cell 89, 1043–1053.
Barth, K.A., Wilson, S.W., 1995. Expression of zebraﬁsh nk2.2 is inﬂuenced by sonic
hedgehog vertebrate hedgehog-1 and demarcates a zone of neuronal differentia-
tion in the embryonic forebrain. Development 121, 1755–1768.
Bose, J., Grotewold, L., Ruther, U., 2002. Pallister–Hall syndrome phenotype in mice
mutant for Gli3. Hum. Mol. Genet. 11, 1129–1135.
Briscoe, J., Pierani, A., Jessell, T.M., Ericson, J., 2000. A homeodomain protein code
speciﬁes progenitor cell identity and neuronal fate in the ventral neural tube. Cell
101, 435–445.
Cayuso, J., Ulloa, F., Cox, B., Briscoe, J., Marti, E., 2006. The Sonic hedgehog pathway
independently controls the patterning, proliferation and survival of neuroepithelial
cells by regulating Gli activity. Development 133, 517–528.
Concordet, J.P., Lewis, K.E., Moore, J.W., Goodrich, L.V., Johnson, R.L., Scott, M.P., Ingham,
P.W., 1996. Spatial regulation of a zebraﬁsh patched homologue reﬂects the roles of
sonic hedgehog and protein kinase A in neural tube and somite patterning.
Development 122, 2835–2846.
Dessaud, E., Yang, L.L., Hill, K., Cox, B., Ulloa, F., Ribeiro, A., Mynett, A., Novitch, B.G.,
Briscoe, J., 2007. Interpretation of the sonic hedgehog morphogen gradient by a
temporal adaptation mechanism. Nature 450, 717–720.
Dutta, S., Dietrich, J.E., Aspock, G., Burdine, R.D., Schier, A., Westerﬁeld, M., Varga, Z.M.,
2005. pitx3 deﬁnes an equivalence domain for lens and anterior pituitary placode.
Development 132, 1579–1590.
Dutta, S., Dietrich, J.E., Westerﬁeld, M., Varga, Z.M., 2008. Notch signaling regulates
endocrine cell speciﬁcation in the zebraﬁsh anterior pituitary. Dev. Biol. 319, 248–257.
Ekker, S.C., Ungar, A.R., Greenstein, P., von Kessler, D.P., Porter, J.A., Moon, R.T., Beachy,
P.A., 1995. Patterning activities of vertebrate hedgehog proteins in the developing
eye and brain. Curr. Biol. 5, 944–955.
Ezzat, S., Asa, S.L., Couldwell, W.T., Barr, C.E., Dodge, W.E., Vance, M.L., McCutcheon, I.E.,
2004. The prevalence of pituitary adenomas: a systematic review. Cancer 101,
613–619.Guner, B., Ozacar, A.T., Thomas, J.E., Karlstrom, R.O., 2008. Graded hedgehog and
ﬁbroblast growth factor signaling independently regulate pituitary cell fates and
help establish the pars distalis and pars intermedia of the zebraﬁsh adenohypo-
physis. Endocrinology 149, 4435–4451.
Herzog, W., Zeng, X., Lele, Z., Sonntag, C., Ting, J.W., Chang, C.Y., Hammerschmidt, M.,
2003. Adenohypophysis formation in the zebraﬁsh and its dependence on sonic
hedgehog. Dev. Biol. 254, 36–49.
Herzog, W., Sonntag, C., von der Hardt, S., Roehl, H.H., Varga, Z.M., Hammerschmidt, M.,
2004. Fgf3 signaling from the ventral diencephalon is required for early
speciﬁcation and subsequent survival of the zebraﬁsh adenohypophysis. Develop-
ment 131, 3681–3692.
Incardona, J.P., Gafﬁeld, W., Kapur, R.P., Roelink, H., 1998. The teratogenic Veratrum
alkaloid cyclopamine inhibits sonic hedgehog signal transduction. Development
125, 3553–3562.
Ingham, P.W., McMahon, A.P., 2001. Hedgehog signaling in animal development:
paradigms and principles. Genes Dev. 15, 3059–3087.
Jacob, J., Briscoe, J., 2003. Gli proteins and the control of spinal-cord patterning. EMBO
Rep. 4, 761–765.
Kalff-Suske, M., Wild, A., Topp, J., Wessling, M., Jacobsen, E.M., Bornholdt, D., Engel, H.,
Heuer, H., Aalfs, C.M., Ausems, M.G., Barone, R., Herzog, A., Heutink, P., Homfray, T.,
Gillessen-Kaesbach, G., Konig, R., Kunze, J., Meinecke, P.,Muller, D., Rizzo, R., Strenge,
S., Superti-Furga, A., Grzeschik, K.H., 1999. Point mutations throughout the GLI3
gene cause Greig cephalopolysyndactyly syndrome. Hum. Mol. Genet. 8, 1769–1777.
Karlstrom, R.O., Trowe, T., Klostermann, S., Baier, H., Brand, M., Crawford, A.D.,
Grunewald, B., Haffter, P., Hoffmann, H., Meyer, S.U., Muller, B.K., Richter, S., van
Eeden, F.J., Nusslein-Volhard, C., Bonhoeffer, F., 1996. Zebraﬁsh mutations affecting
retinotectal axon pathﬁnding. Development 123, 427–438.
Karlstrom, R.O., Talbot, W.S., Schier, A.F., 1999. Comparative synteny cloning of zebraﬁsh
you-too: mutations in the Hedgehog target gli2 affect ventral forebrain patterning.
Genes Dev. 13, 388–393.
Karlstrom, R.O., Tyurina, O.V., Kawakami, A., Nishioka, N., Talbot, W.S., Sasaki, H., Schier,
A.F., 2003. Genetic analysis of zebraﬁsh gli1 and gli2 reveals divergent requirements
for gli genes in vertebrate development. Development 130, 1549–1564.
Ke, Z., Emelyanov, A., Lim, S.E., Korzh, V., Gong, Z., 2005. Expression of a novel zebraﬁsh
zinc ﬁnger gene, gli2b, is affected in Hedgehog and Notch signaling related mutants
during embryonic development. Dev. Dyn. 232, 479–486.
Ke, Z., Kondrichin, I., Gong, Z., Korzh, V., 2008. Combined activity of the two Gli2 genes
of zebraﬁsh play a major role in Hedgehog signaling during zebraﬁsh neurodeve-
lopment. Mol. Cell. Neurosci. 37, 388–401.
Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B., Schilling, T.F., 1995. Stages of
Embryonic Development of the Zebraﬁsh. Dev. Dyn. 203, 253–310.
Kondoh, H., Uchikawa, M., Yoda, H., Takeda, H., Furutani-Seiki, M., Karlstrom, R.O., 2000.
Zebraﬁsh mutations in Gli-mediated hedgehog signaling lead to lens transdiffer-
entiation from the adenohypophysis anlage. Mech. Dev. 96, 165–174.
Kouki, T., Imai, H., Aoto, K., Eto, K., Shioda, S., Kawamura, K., Kikuyama, S., 2001.
Developmental origin of the rat adenohypophysis prior to the formation of Rathke's
pouch. Development 128, 959–963.
Liem, K.F., Bemis, W.E., Walker Jr., W.F., Grande, L., 2001. Functional Anatomy of the
Vertebrates. Harcourt College Publishers, New York, New York.
Liu, N.A., Huang, H., Yang, Z., Herzog, W., Hammerschmidt, M., Lin, S., Melmed, S., 2003.
Pituitary corticotroph ontogeny and regulation in transgenic zebraﬁsh. Mol.
Endocrinol. 17, 959–966.
Liu, N.A., Ren, M., Song, J., Rios, Y., Wawrowsky, K., Ben-Shlomo, A., Lin, S., Melmed, S.,
2008. In vivo time-lapse imaging delineates the zebraﬁsh pituitary proopiomela-
nocortin lineage boundary regulated by FGF3 signal. Dev. Biol. 319, 192–200.
Methot, N., Basler, K., 2001. An absolute requirement for Cubitus interruptus in
Hedgehog signaling. Development 128, 733–742.
Ming, J.E., Roessler, E., Muenke, M.,1998. Human developmental disorders and the Sonic
hedgehog pathway. Mol. Med. Today 4, 343–349.
Pogoda, H.M., Hammerschmidt, M., 2007. Molecular genetics of pituitary development
in zebraﬁsh. Semin. Cell Dev. Biol. 18, 543–558.
Roessler, E., Du, Y.Z., Mullor, J.L., Casas, E., Allen, W.P., Gillessen-Kaesbach, G., Roeder,
E.R., Ming, J.E., Ruiz i Altaba, A., Muenke, M., 2003. Loss-of-function mutations in
the human GLI2 gene are associated with pituitary anomalies and holoprosence-
phaly-like features. Proc. Natl. Acad. Sci. U. S. A. 100, 13424–13429.
Ruiz i Altaba, A., 1999. Gli proteins encode context-dependent positive and negative
functions: implications for development and disease. Development 126,
3205–3216.
Ruiz i Altaba, A., Stecca, B., Sanchez, P., 2004. Hedgehog-Gli signaling in brain tumors:
stem cells and paradevelopmental programs in cancer. Cancer Lett. 204, 145–157.
Ruiz i Altaba, A., Mas, C., Stecca, B., 2007. The Gli code: an information nexus regulating
cell fate, stemness and cancer. Trends Cell Biol. 17, 438–447.
Sbrogna, J.L., Barresi, M.J., Karlstrom, R.O., 2003. Multiple roles for Hedgehog signaling
in zebraﬁsh pituitary development. Dev. Biol. 254, 19–35.
Schlosser, G., 2006. Induction and speciﬁcation of cranial placodes. Dev. Biol. 294,
303–351.
Scott, M.P., 2003. Cancer: a twist in a hedgehog's tale. Nature 425, 780–782.
Seo, H.C., Saetre, B.O., Havik, B., Ellingsen, S., Fjose, A., 1998. The zebraﬁsh Pax3 and Pax7
homologues are highly conserved, encode multiple isoforms and show dynamic
segment-like expression in the developing brain. Mech. Dev. 70, 49–63.
Stamataki, D., Ulloa, F., Tsoni, S.V., Mynett, A., Briscoe, J., 2005. A gradient of Gli activity
mediates graded Sonic Hedgehog signaling in the neural tube. Genes Dev. 19,
626–641.
te Welscher, P., Zuniga, A., Kuijper, S., Drenth, T., Goedemans, H.J., Meijlink, F., Zeller, R.,
2002. Progression of vertebrate limb development through SHH-mediated
counteraction of GLI3. Science 298, 827–830.
154 C.A. Devine et al. / Developmental Biology 326 (2009) 143–154Treier, M., O'Connell, S., Gleiberman, A., Price, J., Szeto, D.P., Burgess, R., Chuang, P.T.,
McMahon, A.P., Rosenfeld, M.G., 2001. Hedgehog signaling is required for pituitary
gland development. Development 128, 377–386.
Tyurina, O.V., Guner, B., Popova, E., Feng, J., Schier, A.F., Kohtz, J.D., Karlstrom, R.O., 2005.
Zebraﬁsh Gli3 functions as both an activator and a repressor in Hedgehog signaling.
Dev. Biol. 277, 537–556.
Vanderlaan, G., Tyurina, O.V., Karlstrom, R.O., Chandrasekhar, A., 2005. Gli function is
essential for motor neuron induction in zebraﬁsh. Dev. Biol. 282, 550–570.
Varga, Z.M., Amores, A., Lewis, K.E., Yan, Y.L., Postlethwait, J.H., Eisen, J.S., Westerﬁeld,
M., 2001. Zebraﬁsh smoothened functions in ventral neural tube speciﬁcation and
axon tract formation. Development 128, 3497–3509.Vila, G., Theodoropoulou, M., Stalla, J., Tonn, J.C., Losa, M., Renner, U., Stalla, G.K., Paez-
Pereda, M., 2005. Expression and function of sonic hedgehog pathway components
in pituitary adenomas: evidence for a direct role in hormone secretion and cell
proliferation. J. Clin. Endocrinol. Metab. 90, 6687–6694.
Villaplana, M., Garcia Ayala, A., Chaves Pozo, E., Agulleiro, B., 2000. Identiﬁcation of
mammosomatotropes, growth hormone cells and prolactin cells in the pituitary
gland of the gilthead sea bream (Sparus aurata L., Teleostei) using light
immunocytochemical methods: an ontogenetic study. Anat. Embryol. (Berl) 202,
421–429.
Wilson, D.B., Wyatt, D.P., 1986. Ultrastructural immunocytochemistry of somatotrophs
andmammotrophs in embryos of the dwarfmutantmouse. Anat. Rec. 215, 282–287.
